CSBR:NASDAQ
Champions Oncology Inc
4,34 USD
arrow_downward
-1,36%(-0,060) 1D
20-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,45 USD
High
4,45 USD
Low
4,34 USD
Mkt. cap
60,41 млн
Avg. vol.
6,97 миң
Volume
8,94 миң
52-wk high
8,31 USD
52-wk low
4,34 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
Open
4,45 USD
High
4,45 USD
Low
4,34 USD
Mkt. cap
60,41 млн
Avg. vol.
6,97 миң
Volume
8,94 миң
52-wk high
8,31 USD
52-wk low
4,34 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
News stories
From web sources and news partners
AP News
·
15 саат мурун
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
Trefis
·
6 саат мурун
S&P 500 Movers | Winners: GPN, GIS, MKC | Losers: BE, NVDA, LITE
Beinsure
·
4 саат мурун
S&P 500 forecast for 2027: Wall Street expects a rebound after an 11.6% drop fueled by AI fears
Scripps News
·
7 саат мурун
AI stock sell-off sends S&P 500 into correction, Nasdaq negative for year
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersХаккенсак, Нью Джерси, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websitechampionsoncology.com